FAM8A2P

Across TCGA pan-cancer cohorts, FAM8A2P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of FAM8A2P’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where FAM8A2P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FAM8A2P is over-expressed in tumor.

UCEC, LUSC, and LUAD are the cancer types where FAM8A2P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAM8A2P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	IV	+0.180	.012	2	view →
LUSC	All	All	+0.111	.038	1	view →
LUAD	All	All	+0.026	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

FAM8A2P–UCEC

Open the UCEC breakdown →